Michael R. Pompeo, Secretary of State
QUESTION: Earlier this week, my colleague, Bret Baier, had an exclusive interview with Secretary of State Mike Pompeo. Here’s the second part of that conversation.
QUESTION: Joining us now, the Secretary of State of the United States, Mike Pompeo.
SECRETARY POMPEO: Great to be back with you, Bret. Thank you.
QUESTION: The last time we talked, you had just come off saying that the Trump administration would be into its second term, essentially. You have come to the conclusion that this transition process is happening even as the legal challenges continue? Will you be right-seat/left-seating with the incoming team?
SECRETARY POMPEO: I remember when I was the incoming guy at the Central Intelligence Agency. The United States has one secretary of state at a time, but we know right-seat/left-seat. We’ll have one secretary of state and one president for the duration. But those things that are required that the President has directed us to do in compliance with the decision that the GSA made yesterday, we’ll do all of those things. It’s a legal requirement, and we’ll always honor that promise.
QUESTION: When it comes to Afghanistan, where are you on zero troops in Afghanistan?
SECRETARY POMPEO: Well, it’s the mission set.
QUESTION: But I mean before January 20th?
SECRETARY POMPEO: Well, the President will obviously make the decision on that. The President to date has said that we’re going to go from where we are today, something just over 4,000, to around 2,500. But Bret, don’t fall in the trap of thinking about America’s security related to the number of soldiers on the ground in any one place. The threat from terrorism around the world – from Islamic extremism, Islamic terrorism – is real. It doesn’t just emanate from Afghanistan.
We have the force posture right today. We’re going to keep it right. We’ll get our troops home when we can, and we’ll do the things we need to do. If Qasem Soleimani is a problem, we’ll go crush them. If Hamza bin Ladin presents a risk, we’ll take him out. President Trump has been very clear we’re going to protect and secure the homeland, but we’re not going to have our young men and women in harm’s way when it doesn’t deliver real security benefits for the United States and for our allies.
QUESTION: I guess some people look at it when you stood for that photo with the Taliban in February and the signed accord and the negotiations were still ongoing, the deal was down to 4,500, not 2,500. Was that somehow changed by the troop numbers that the President put out, and did it hurt the negotiations with the Taliban?
SECRETARY POMPEO: No, Bret, the agreement we signed in February talked about getting down to zero by May based on a set of conditions on the ground. That was what we’d agreed to. We have made some progress. We’ve had significant prisoner releases. We have violence levels that have reduced risks to Americans significantly over this time period since February of last year.
Afghanistan’s violence levels are still higher than they need to be. I was with the Afghan Government negotiators and with the Taliban negotiators just this past weekend in Dota, Qatar. I talked to each of them about the need to continue to conduct the negotiations which will lead to a unified, independent Afghanistan that protects all the gains that have been made over these past years, and the fact that they need to take violence levels down even further, and that the Taliban need to honor the commitment they made to make sure that there’s not a terror attack that takes place from Afghan soil.
Those are the parts of the negotiation that continue. There is still work to do, but we’re headed in the right direction. We are safer here in the United States today as a result of the things the Trump administration has done not only in Afghanistan but throughout that region.
QUESTION: What is your most memorable moment as Secretary of State?
SECRETARY POMPEO: Bret, that’s a great question. I haven’t had a chance to reflect on it. I guess if I were to give you my quick response, it was really something to come back from Pyongyang with three Americans and travel home with them from Asia and return them to their families. Those folks had been held in harm’s way. They were at real risk, and we got a chance to bring three Americans home that morning back at the very beginning of my time as Secretary of State. It was pretty special to do that.
QUESTION: What’s next for you? Elected office, private sector? What is it?
SECRETARY POMPEO: It’s hard to know, Bret. We’ll keep doing this until we’re tapped on the shoulder and told it’s no longer time to be the Secretary of State, and then Susan and I will figure that out.
QUESTION: Mr. Secretary, thank you.
Greetings I’m Sam.
I edit, report and maintain this site. If you have any questions You can mail below me but it could be a while before I get back to you.
- Owner and Operator of India-Based Call Centers Sentenced to Prison for Scamming U.S. Victims out of Millions of DollarsBy Sam NewsNovember 30, 2020An Indian national was sentenced today to 20 years in prison followed by three years of supervised release in the Southern District of Texas for his role in operating and funding India-based call centers that defrauded U.S. victims out of millions of dollars between 2013 and 2016.[Read More…]
- Iran and China, the Totalitarian TwinsBy Sam NewsSeptember 27, 2020Keith Krach, Under [Read More…]
- The Department of State Dedicates the New U.S. Embassy in Niamey, NigerBy Sam NewsMarch 17, 2021
- Information Technology: Agencies Need to Develop and Implement Modernization Plans for Critical Legacy SystemsBy Sam NewsApril 27, 2021What GAO Found In June 2019, GAO identified 10 critical federal information technology (IT) legacy systems that were most in need of modernization. These legacy systems provided vital support to agencies' missions. According to the agencies, these legacy systems ranged from about 8 to 51 years old and, collectively, cost about $337 million annually to operate and maintain. Several of the systems used older languages, such as Common Business Oriented Language (COBOL). GAO has previously reported that reliance on such languages has risks, such as a rise in procurement and operating costs, and a decrease in the availability of individuals with the proper skill sets. Further, several of the legacy systems were operating with known security vulnerabilities and unsupported hardware and software. Of the 10 agencies responsible for these legacy systems, GAO reported in June 2019 that seven agencies (the Departments of Defense, Homeland Security, the Interior, the Treasury; as well as the Office of Personnel Management; Small Business Administration; and Social Security Administration) had documented plans for modernizing the systems (see table). Of the seven agencies with plans, only the Departments of the Interior's and Defense's modernization plans included all of the key elements identified in best practices (milestones, a description of the work necessary to complete the modernization, and a plan for the disposition of the legacy system). The other five agencies lacked complete modernization plans. The Departments of Education, Health and Human Services, and Transportation did not have documented modernization plans. Table: Extent to Which Agencies' Had Documented Modernization Plans for Legacy Systems That Included Key Elements, as of June 2019 Agency Included milestones to complete the modernization Described work necessary to modernize system Summarized planned disposition of legacy system Department of Defense Yes Yes Yes Department of Education n/a – did not have a documented modernization plan Department of Health and Human Services n/a – did not have a documented modernization plan Department of Homeland Security No Yes No Department of the Interior Yes Yes Yes Department of the Treasury Partial Yes No Department of Transportation n/a – did not have a documented modernization plan Office of Personnel Management Partial Partial No Small Business Administration Yes No Yes Social Security Administration Partial Partial No Source: GAO analysis of agency modernization plans. | GAO-21-524T Agencies received a “partial” if the element was completed for a portion of the modernization. GAO stressed that, until the eight agencies established complete plans, their modernizations would face an increased risk of cost overruns, schedule delays, and project failure. Accordingly, GAO recommended that each of the eight develop such plans. However, to date, seven of the agencies had not done so. It is essential that agencies implement GAO's recommendations and these plans in order to meet mission needs, address security risks, and reduce operating costs. Why GAO Did This Study Each year, the federal government spends more than $100 billion on IT and cyber-related investments. Of this amount, agencies have typically spent about 80 percent on the operations and maintenance of existing IT investments, including legacy systems. However, federal legacy systems are becoming increasingly obsolete. In May 2016, GAO reported instances where agencies were using systems that had components that were at least 50 years old or the vendors were no longer providing support for hardware or software. Similarly, in June 2019 GAO reported that several of the federal government's most critical legacy systems used outdated languages, had unsupported hardware and software, and were operating with known security vulnerabilities. GAO was asked to testify on its June 2019 report on federal agencies' legacy systems. Specifically, GAO summarized (1) the critical federal legacy systems that we identified as most in need of modernization and (2) its evaluation of agencies' plans for modernizing them. GAO also provided updated information regarding agencies' implementation of its related recommendations.[Read More…]
- Beam Suntory Inc. Agrees to Pay Over $19 Million to Resolve Criminal Foreign Bribery CaseBy Sam NewsOctober 27, 2020Beam Suntory Inc. (Beam), a Chicago-based company that produces and sells distilled beverages, has agreed to pay a criminal monetary penalty of $19,572,885 to resolve the department’s investigation into violations of the Foreign Corrupt Practices Act (FCPA).[Read More…]
- Medicare Part B: Payments and Use for Selected New, High-Cost DrugsBy Sam NewsMarch 1, 2021Hospital outpatient departments perform a wide range of procedures, including diagnostic and surgical procedures, which may use drugs that Medicare considers to function as supplies. If the drug is new, and its cost is high relative to Medicare's payment for the procedure, then hospitals can receive a separate “pass-through” payment for the drug in addition to Medicare's payment for the procedure. These pass-through payments are in effect for 2 to 3 years. When the pass-through payments expire, Medicare no longer pays separately for the drug, and payment for the drug is “packaged” with the payment for the related procedure. The payment rate for the procedure does not vary by whether or not the drug is used. Medicare intends this payment rate to be an incentive for hospitals to furnish services efficiently, such as using the most cost-efficient items that meet the patient's needs. Examples of Types of Drugs that Medicare Considers to Function as Supplies GAO's analysis of Medicare data showed that higher payments were associated with six of seven selected drugs when they were eligible for pass-through payments versus when their payments were packaged. For example, one drug used in cataract removal procedures was eligible for pass-through payments in 2017. That year, Medicare paid $1,824 for the procedure and $463 for the drug pass-through payment—a total payment of $2,287. If a hospital performed the same cataract removal procedure when the drug was packaged the following year, there was no longer a separate payment for the drug. Instead, Medicare paid $1,921 for the procedure whether or not the hospital used the drug. Of the seven selected drugs, GAO also reviewed differences in use for four of them that did not have limitations on Medicare coverage during the time frame of GAO's analysis, such as coverage that was limited to certain clinical trials. GAO found that hospitals' use of three of the four drugs was lower when payments for the drugs were packaged. This was consistent with the financial incentives created by the payment system. In particular, given the lower total payment for the drug and procedure when the drug is packaged, hospitals may have a greater incentive to use a lower-cost alternative for the procedure. Hospitals' use of a fourth drug increased regardless of payment status. The financial incentives for that drug appeared minimal because the total payment for it and its related procedure was about the same when it was eligible for pass-through payments and when packaged. Other factors that can affect use of the drugs include the use of the drugs for certain populations and whether hospitals put the drugs on their formularies, which guide, in part, whether the drug is used at that hospital. The Department of Health and Human Services reviewed a draft of this report and provided technical comments, which GAO incorporated as appropriate. Medicare makes “pass-through” payments under Medicare Part B when hospital outpatient departments use certain new, high-cost drugs. These temporary payments are in addition to Medicare's payments for the procedures using the drugs. They may help make the new drugs accessible for beneficiaries and also allow Medicare to collect information on the drugs' use and costs. The Consolidated Appropriations Act, 2018 included a provision for GAO to review the effect of Medicare's policy for packaging high-cost drugs after their pass-through payments have expired. This report describes (1) the payments associated with selected high-cost drugs when eligible for pass-through payments versus when packaged, and (2) hospitals' use of those drugs when eligible for pass-through payments versus when packaged. GAO reviewed federal regulations on pass-through payments and Medicare payment files for all seven drugs whose pass-through payments expired in 2017 or 2018 and that were subsequently packaged. All of these drugs met Medicare's definition for having a high cost relative to Medicare's payment rate for the procedure using the drug. GAO also reviewed Medicare claims data on the use of the drugs for 2017 through 2019 (the most recent available). To supplement this information, GAO also interviewed Medicare officials, as well officials from 11 organizations representing hospitals, physicians, and drug manufacturers, about payment rates, use, reporting, and clinical context for the drugs. For more information, contact James Cosgrove at (202) 512-7114 or email@example.com.[Read More…]
- Two Owners of New York Pharmacies Charged in a $30 Million COVID-19 Health Care Fraud and Money Laundering CaseBy Sam NewsDecember 21, 2020The owners of over a dozen New York-area pharmacies were charged in an indictment unsealed today for their roles in a $30 million health care fraud and money laundering scheme, in which they exploited emergency codes and edits in the Medicare system that went into effect due to the COVID-19 pandemic in order to submit fraudulent claims for expensive cancer drugs that were never provided, ordered, or authorized by medical professionals.[Read More…]
- On the Political Persecution of Hong Kong Democracy AdvocatesBy Sam NewsDecember 3, 2020
- Pharmacy Owner Pleads Guilty to $6.5 million Health Care Fraud SchemesBy Sam NewsApril 21, 2021A New York woman pleaded guilty today to perpetrating schemes to defraud health care programs, including obtaining more than $6.5 million from Medicare Part D Plans and Medicaid drug plans.[Read More…]
- Philippines Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel to the [Read More…]
- Guinea-Bissau Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel to [Read More…]
- U.S. Announces Additional Humanitarian Assistance for the Tigray Crisis ResponseBy Sam NewsMarch 18, 2021
- U.S. Department of State and National Park Service Partner to Strengthen Fulbright Exchanges and Increase Global Environmental AwarenessBy Sam NewsJanuary 14, 2021
- Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesBy Sam NewsFebruary 11, 2021Operation Warp Speed (OWS)—a partnership between the Departments of Health and Human Services (HHS) and Defense (DOD)—aimed to help accelerate the development of a COVID-19 vaccine. GAO found that OWS and vaccine companies adopted several strategies to accelerate vaccine development and mitigate risk. For example, OWS selected vaccine candidates that use different mechanisms to stimulate an immune response (i.e., platform technologies; see figure). Vaccine companies also took steps, such as starting large-scale manufacturing during clinical trials and combining clinical trial phases or running them concurrently. Clinical trials gather data on safety and efficacy, with more participants in each successive phase (e.g., phase 3 has more participants than phase 2). Vaccine Platform Technologies Supported by Operation Warp Speed, as of January 2021 As of January 30, 2021, five of the six OWS vaccine candidates have entered phase 3 clinical trials, two of which—Moderna's and Pfizer/BioNTech's vaccines—have received an emergency use authorization (EUA) from the Food and Drug Administration (FDA). For vaccines that received EUA, additional data on vaccine effectiveness will be generated from further follow-up of participants in clinical trials already underway before the EUA was issued. Technology readiness. GAO's analysis of the OWS vaccine candidates' technology readiness levels (TRL)—an indicator of technology maturity— showed that COVID-19 vaccine development under OWS generally followed traditional practices, with some adaptations. FDA issued specific guidance that identified ways that vaccine development may be accelerated during the pandemic. Vaccine companies told GAO that the primary difference from a non-pandemic environment was the compressed timelines. To meet OWS timelines, some vaccine companies relied on data from other vaccines using the same platforms, where available, or conducted certain animal studies at the same time as clinical trials. However, as is done in a non-pandemic environment, all vaccine companies gathered initial safety and antibody response data with a small number of participants before proceeding into large-scale human studies (e.g., phase 3 clinical trials). The two EUAs issued in December 2020 were based on analyses of clinical trial participants and showed about 95 percent efficacy for each vaccine. These analyses included assessments of efficacy after individuals were given two doses of vaccine and after they were monitored for about 2 months for adverse events. Manufacturing. As of January 2021, five of the six OWS vaccine companies had started commercial scale manufacturing. OWS officials reported that as of January 31, 2021, companies had released 63.7 million doses—about 32 percent of the 200 million doses that, according to OWS, companies with EUAs have been contracted to provide by March 31, 2021. Vaccine companies face a number of challenges in scaling up manufacturing to produce hundreds of millions of doses under OWS's accelerated timelines. DOD and HHS are working with vaccine companies to help mitigate manufacturing challenges, including: Limited manufacturing capacity: A shortage of facilities with capacity to handle the vaccine manufacturing needs can lead to production bottlenecks. Vaccine companies are working in partnership with OWS to expand production capacity. For example, one vaccine company told GAO that HHS's Biomedical Advanced Research and Development Authority helped them identify an additional manufacturing partner to increase production. Additionally, the U.S. Army Corps of Engineers is overseeing construction projects to expand capacity at vaccine manufacturing facilities. Disruptions to manufacturing supply chains: Vaccine manufacturing supply chains have been strained by the global demand for certain goods and workforce disruptions caused by the global pandemic. For example, representatives from one facility manufacturing COVID-19 vaccines stated that they experienced challenges obtaining materials, including reagents and certain chemicals. They also said that due to global demand, they waited 4 to 12 weeks for items that before the pandemic were typically available for shipment within one week. Vaccine companies and DOD and HHS officials told GAO they have undertaken several efforts to address possible manufacturing disruptions and mitigate supply chain challenges. These efforts include federal assistance to (1) expedite procurement and delivery of critical manufacturing equipment, (2) develop a list of critical supplies that are common across the six OWS vaccine candidates, and (3) expedite the delivery of necessary equipment and goods coming into the United States. Additionally, DOD and HHS officials said that as of December 2020 they had placed prioritized ratings on 18 supply contracts for vaccine companies under the Defense Production Act, which allows federal agencies with delegated authority to require contractors to prioritize those contracts for supplies needed for vaccine production. Gaps in the available workforce: Hiring and training personnel with the specialized skills needed to run vaccine manufacturing processes can be challenging. OWS officials stated that they have worked with the Department of State to expedite visa approval for key technical personnel, including technicians and engineers to assist with installing, testing, and certifying critical equipment manufactured overseas. OWS officials also stated that they requested that 16 DOD personnel be detailed to serve as quality control staff at two vaccine manufacturing sites until the organizations can hire the required personnel. As of February 5, 2021, the U.S. had over 26 million cumulative reported cases of COVID-19 and about 449,020 reported deaths, according to the Centers for Disease Control and Prevention. The country also continues to experience serious economic repercussions, with the unemployment rate and number of unemployed in January 2021 at nearly twice their pre-pandemic levels in February 2020. In May 2020, OWS was launched and included a goal of producing 300 million doses of safe and effective COVID-19 vaccines with initial doses available by January 2021. Although FDA has authorized two vaccines for emergency use, OWS has not yet met its production goal. Such vaccines are crucial to mitigate the public health and economic impacts of the pandemic. GAO was asked to review OWS vaccine development efforts. This report examines: (1) the characteristics and status of the OWS vaccines, (2) how developmental processes have been adapted to meet OWS timelines, and (3) the challenges that companies have faced with scaling up manufacturing and the steps they are taking to address those challenges. GAO administered a questionnaire based on HHS's medical countermeasures TRL criteria to the six OWS vaccine companies to evaluate the COVID-19 vaccine development processes. GAO also collected and reviewed supporting documentation on vaccine development and conducted interviews with representatives from each of the companies on vaccine development and manufacturing. For more information, contact Karen L. Howard and Candice N. Wright at (202) 512-6888 or firstname.lastname@example.org or email@example.com.[Read More…]
- Texas man headed to prison for trying to sexually entice minorBy Sam NewsIn Justice NewsMay 2, 2021A 49-year-old Austin man [Read More…]
- Secretary Pompeo’s Call with Foreign Minister Mahuta By Sam NewsNovember 11, 2020
- United States Sanctions Five Iranian Entities and Watchlists IRGC Cyber Actors for Interfering in Our ElectionsBy Sam NewsOctober 23, 2020
- Joint Press Statement on the 11th U.S.-Japan Policy Cooperation Dialogue on the Internet EconomyBy Sam NewsSeptember 26, 2020
- Home Foreclosure Sales: FHA, Rural Housing Service, and VA Could Better Align Program Metrics with Their MissionsBy Sam NewsMarch 5, 2021By 2019, the number of foreclosed properties—known as real estate-owned (REO) properties—that federal entities owned declined to historically low levels because of the housing market recovery and the sale of many of the properties (see figure). Real Estate-Owned Properties of Selected Federal Entities, 2004–2019 Note: Fannie Mae and Freddie Mac are the government-sponsored enterprises shown here. Data for the enterprises and FHA are calendar year; for VA and RHS, fiscal year ending September 30. The entities GAO reviewed each have processes to oversee their REO maintenance contractors' activities and performance, including internal and external performance reviews and on-site inspections. Entities generally have standardized maintenance policies for REO properties across the country, such as emergency repairs for broken windows and routine maintenance requirements for the frequency of cutting grass. GAO found that the performance of contractors whose documentation GAO reviewed generally met entities' standards and requirements. However, entities' oversight of contractors identified instances of underperformance in maintenance. For instance, the Federal Housing Administration (FHA) recouped almost $3 million from seven property maintenance contractors for work below quality standards from 2017 to 2020. The REO program metrics of FHA, the Department of Veterans Affairs (VA), and the Rural Housing Service (RHS) focus on required financial goals, such as minimizing losses, but do not always align fully with other program goals or agency missions. For example, FHA does not collect comprehensive information on REO property sales to public-sector homeowners or local nonprofits—missing an opportunity to measure the extent to which its REO program supports its goal to strengthen neighborhoods and communities. Similarly, VA and RHS lack metrics that would show whether their REO programs align with their broader agency missions to serve veterans and rural homebuyers, respectively. Incorporating additional metrics could help FHA, VA, and RHS ensure that their REO programs assist in meeting their agencies' missions. Poor maintenance of foreclosed properties can negatively affect communities and threaten neighborhood stability. FHA, VA, RHS, and Freddie Mac are among the federal entities owning foreclosed properties through REO programs. GAO was asked to review how these federal entities monitor REO property conditions. The objectives this report examines include trends in the number of REO properties; oversight of maintenance contractors; and whether metrics used to assess REO program performance align with entities' missions. GAO reviewed and analyzed reports and data on the number of REO properties and documentation on FHA, Freddie Mac, VA, and RHS oversight of REO property maintenance from 2017 to 2020. GAO also analyzed data on REO reimbursements to contractors for maintenance activities. GAO recommends that FHA, VA, and RHS consider additional REO program metrics that measure how the programs support their respective missions of strengthening communities and serving veterans and rural homeowners. The entities generally agreed with the recommendation. For more information, contact John H. Pendleton at (202) 512-8678 or firstname.lastname@example.org.[Read More…]
- Man Sentenced for Engaging in Illicit Sexual Conduct with Minors in the Republic of KenyaBy Sam NewsFebruary 4, 2021A Pennsylvania man was sentenced today to over 15 years in prison plus a lifetime of supervised release, and ordered to pay $16,000 in restitution for engaging in illicit sexual conduct in a foreign place.[Read More…]
- Disqualification of Pan-Democratic Lawmakers in Hong KongBy Sam NewsNovember 12, 2020
- NASA’s Cold Atom Lab Takes One Giant Leap for Quantum ScienceBy Sam NewsSeptember 26, 2020A new study describes [Read More…]
- Special Representative for Iran and Venezuela Elliott Abrams Travels to Middle EastBy Sam NewsNovember 7, 2020
- On the Anniversary of the Marine Barracks Terrorist Attack By Sam NewsOctober 23, 2020
- Deputy Assistant Attorney General Richard A. Powers Delivers Remarks at Cartel Working Group Plenary: Big Data and Cartelization, 2020 International Competition Network Annual ConferenceBy Sam NewsSeptember 17, 2020Virtual Event Good [Read More…]
- Nigeria Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel [Read More…]
- Justice Department Invests $2.6 Million to Mitigate Violent Crime and Support Public Safety in Disruption EffortsBy Sam NewsNovember 10, 2020The Department of Justice announced awards from the Office of Justice Programs (OJP) totaling $2.6 million to four jurisdictions to disrupt and mitigate threats of violence. The funds support state and local prosecutors and investigators who seek expertise from mental health and threat assessment experts to identify these individuals and prevent violent acts.[Read More…]
- Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual PropertyBy Sam NewsNovember 20, 2020Research conducted at Department of Health and Human Services (HHS) labs led to 4,446 U.S. patents owned by the agency covering a range of inventions from 1980 through 2019. During that period, the National Institutes of Health (NIH) had 93 patents—2 percent of the total—that contributed to the successful development of 34 drugs approved by the Food and Drug Administration (FDA) and brought to market, including vaccines and treatments for cancer. These 34 drugs were developed by pharmaceutical companies and were associated with 32 licenses granted to them by NIH. As shown in the figure, these licenses have generated up to $2 billion in royalty revenue for NIH since 1991, when FDA approved the first of these drugs. Three licenses generated more than $100 million each for the agency. Royalties from NIH Licenses of Inventions Associated with FDA-Approved Drugs, 1991 to February 2020 When licensing its inventions, NIH prioritizes the likelihood that the licensee can successfully develop a drug by considering such factors as technical expertise and the ability to raise capital. Consistent with federal interpretation of technology transfer statutory authorities, NIH does not consider the affordability of the resulting drug. NIH provides limited information to the public about its licensing activities. For example, the agency does not report which of its patents are licensed or release metrics that would enable the public to evaluate how licensing affects patient access to resulting drugs. Increasing the transparency of its licensing activities could improve the public’s and policymakers’ understanding of NIH’s management of its intellectual property. HHS monitors for unauthorized use of its inventions (infringement) and has taken steps to protect its rights. HHS relies primarily on inventors at its labs to monitor for potential infringement and generally encourages potential infringers to license the inventions. If cases proceed to litigation, HHS relies on the Department of Justice (DOJ) to protect its rights. Since 2009, HHS has worked with DOJ to defend its intellectual property in several cases in the U.S. and abroad and has referred one case to DOJ for litigation against an alleged infringer. HHS labs conduct research that can contribute to the development of new life-saving drugs. HHS may grant rights to its inventions by licensing the patents to pharmaceutical companies that conduct the additional development activities and testing necessary to bring drugs to market. Public health experts and patients’ rights advocates have raised concerns about the prices of drugs developed with federal support. GAO was asked to review HHS’s management of its intellectual property. This report examines (1) the extent to which HHS-owned intellectual property has contributed to the development of FDA-approved drugs, (2) what is known about the licenses associated with FDA-approved drugs, (3) factors NIH prioritizes when licensing its inventions and information about licensing it makes public, and (4) steps HHS has taken to protect its rights. GAO reviewed relevant laws and agency documents, analyzed patent and licensing data, and interviewed HHS officials, academic experts, industry representatives, and nongovernmental organizations. GAO is making two recommendations, including that NIH provide more information to the public about the licensing of its intellectual property. HHS concurred with GAO’s recommendations. For more information, contact John Neumann, (202) 512-6888, NeumannJ@gao.gov.[Read More…]
- Texas Heart Hospital and Wholly-Owned Subsidiary THHBP Management Company LLC to Pay $48 Million to Settle False Claims Act Allegations Related to Alleged KickbacksBy Sam NewsDecember 18, 2020Texas Heart Hospital of the Southwest LLP, a partially physician-owned hospital in Plano, Texas, and its wholly owned subsidiary, THHBP Management Company, LLC (collectively, the “Heart Hospital”) have agreed to pay the United States $48 million to resolve claims that the Heart Hospital violated the False Claims Act by knowingly submitting claims to the Medicare program that resulted from violations of the Physician Self-Referral Law and the Anti Kickback Statute, the Justice Department announced today.[Read More…]
- United States Reaches Agreement to Protect New Orleans Waterways and Lake PontchartrainBy Sam NewsSeptember 29, 2020Today, the U.S. Environmental Protection Agency (EPA) and the Department of Justice announced a settlement with the Churchill Downs Louisiana Horseracing Company LLC, d/b/a Fair Grounds Corporation (Fair Grounds) that will resolve years of Clean Water Act (CWA) violations at its New Orleans racetrack. Under the settlement, Fair Grounds will eliminate unauthorized discharges of manure, urine and process wastewater through operational changes and construction projects at an estimated cost of $5,600,000. The company also will pay a civil penalty of $2,790,000, the largest ever paid by a concentrated animal feeding operation in a CWA matter.[Read More…]
- MOXIE Could Help Future Rockets Launch Off MarsBy Sam NewsDecember 9, 2020NASA’s [Read More…]
- Assistant Attorney General Makan Delrahim Delivers Final AddressBy Sam NewsJanuary 19, 2021Thank you very much for that introduction, Matt. I am grateful to Duke University and Duke’s Center on Science & Technology Policy for the privilege of being with you today to share some thoughts about the future of antitrust policy.[Read More…]
- COVID-19: Emergency Financial Aid for College Students under the CARES ActBy Sam NewsApril 20, 2021What GAO Found As of November 2020, the Department of Education (Education) had distributed $6.19 billion in grants to 4,778 schools (colleges and other institutions of higher education) that had applied for emergency student aid funds from the Higher Education Emergency Relief Fund (HEERF) established by the CARES Act, which was enacted in March 2020. After many schools closed their physical campuses in spring 2020 in response to COVID-19, Education provided these grants to schools, based on a statutory formula, to give emergency financial assistance (student aid) to students who incurred related expenses, such as for housing, technology, and course materials. The majority of these HEERF student aid funds have been awarded to public schools (see figure). The average amount Education awarded per school was about $1.3 million, while amounts schools received ranged from less than $2,000 to more than $27 million, with half of schools receiving awards of $422,000 or less. Education data show that, as of November 2020, schools had drawn down about 90 percent—or $5.6 billion—of their HEERF student aid funds. About 70 percent of schools had drawn down all of their student aid funds, and an additional 24 percent of schools had drawn down at least half. Department of Education’s Higher Education Emergency Relief Fund (HEERF) Awards to Schools for Emergency Student Aid under the CARES Act, by School Sector Notes: Schools of less than 2 years are included in the 2-year school categories above. The Department of Education also awarded about $24 million to 2-year private, nonprofit schools and about $1.7 million to the Commonwealth of Puerto Rico Department of Education. Sector-level figures do not add up to $6.19 billion because of rounding. Schools used a variety of approaches to determine student eligibility and distribute funds to students. According to GAO’s analysis of a sample of school websites and data from Education, schools had distributed approximately 85 percent of all emergency student aid funds by fall 2020, with an average amount per student of about $830. Determining student eligibility. Approximately half of schools reported that they required a completed Free Application for Federal Student Aid (FAFSA)—the form used to apply for federal financial aid—to determine student eligibility for HEERF student aid. For example, one school reported requiring students who did not have a FAFSA on file to complete one by June 2020 to be eligible for student aid. Other schools did not require a FAFSA to establish eligibility, according to their websites, but reported using alternative methods. For example, a 4-year public school reported that graduate students applying for emergency aid had the option of submitting a school-provided affidavit certifying they were eligible to receive federal financial aid, an option described in Education’s interim final rule on student eligibility. Awarding funds to students. Schools reported using two main methods for awarding HEERF emergency student aid to students: requiring students to complete a school-developed application or using existing school records. Approximately 18 percent of schools used a combination of both methods. For example, a 4-year nonprofit school reported on its website that it awarded $300 to $500 to eligible students in its first round of funding based on existing student financial aid records, and then allowed students who had more expenses related to COVID-19 to apply for additional funding. Determining award amounts. Schools reported using various factors to determine award amounts for HEERF-eligible students. Over half of schools reported on their websites that amounts were based on individual circumstances, such as students’ general financial need, access to essential items such as food or housing, or a combination of these factors. About 20 percent of schools also reported using full-time or part-time status to determine aid amounts. For example, a 4-year public school reported that it distributed grants, ranging from $150 to $1,000, to all eligible students based on their enrollment status and financial need based on students’ FAFSA information. Why GAO Did This Study In June 2020, GAO issued the first of a series of reports on federal efforts to address the pandemic, which included a discussion of HEERF student aid grants to schools. At that time, limited information on how schools distributed HEERF funds to students was available. This report provides additional information and examines (1) how HEERF emergency student aid funds were provided to schools under the CARES Act, and (2) how schools distributed emergency student aid to eligible students. GAO analyzed Education’s obligation data as of November 2020, after Education had obligated most of the HEERF emergency student aid funds. GAO also analyzed information about HEERF student aid that Education requires schools to report on their websites by selecting a generalizable random sample of 203 schools for website reviews. These schools were representative of the more than 4,500 schools that received HEERF student aid funds as of August 2020. GAO also collected non-generalizable narrative details about how schools distributed funds to eligible students.[Read More…]
- Imposing Sanctions on Russia for the Poisoning and Imprisonment of Aleksey NavalnyBy Sam NewsMarch 2, 2021
- NASA’s AIRS Monitors Tropical Storm Fay as It Deluges the East CoastBy Sam NewsSeptember 26, 2020From its vantage point [Read More…]
- Puerto Rico Legislator and Two Capitol Employees Indicted for Theft and BriberyBy Sam NewsAugust 20, 2020On Wednesday, a federal grand jury in the District of Puerto Rico returned an eight-count indictment against legislator Nelson Del Valle Colon (Del Valle), a member of the Puerto Rico House of Representatives, as well as two of his employees, Nickolle Santos-Estrada (Santos) and her mother Mildred Estrada-Rojas (Estrada), for their alleged participation in a multi-year theft, bribery, and kickback conspiracy.[Read More…]
- Join NASA for the Launch of the Mars 2020 Perseverance RoverBy Sam NewsSeptember 26, 2020No matter where you [Read More…]
- Tanzania Union DayBy Sam NewsApril 26, 2021
- How We Transformed Public Health Data for COVID-19 and the FuturBy Sam NewsJanuary 19, 2021Data is the lifeblood of [Read More…]
- Four Additional Members of Los Angeles-Based Fraud Ring Indicted for Exploiting COVID-Relief ProgramsBy Sam NewsMarch 12, 2021A federal grand jury in Los Angeles returned a superseding indictment, which was unsealed Thursday, charging four additional individuals for their alleged participation in a scheme to submit over 150 fraudulent loan applications seeking over $21.9 million in COVID-19 relief funds guaranteed by the Small Business Administration (SBA) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.[Read More…]
- Atlanta Tax Professionals Plead Guilty to Promoting Syndicated Conservation Easement Tax Scheme Involving More Than $1.2 Billion in Fraudulent Charitable DeductionsBy Sam NewsDecember 21, 2020Stein Agee of Canton, Georgia, and Corey Agee of Atlanta, Georgia, appeared before U.S. Magistrate Judge W. Carleton Metcalf and pleaded guilty for their roles in a wide-ranging abusive tax scheme to defraud the IRS, announced United States Attorney R. Andrew Murray for the Western District of North Carolina, Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division, and Commissioner Charles Rettig of the IRS.[Read More…]
- Escalation of Violence between Armenia and AzerbaijanBy Sam NewsSeptember 27, 2020Morgan Ortagus, [Read More…]
- Wisconsin Pain Management Companies To Settle False Claims Act AllegationsBy Sam NewsOctober 1, 2020The Department of Justice announced today that Advanced Pain Management Holdings Inc. (APMH), its wholly-owned subsidiaries, APM Wisconsin MSO (“APM MSO”) and Advanced Pain Management LLC (APM LLC); and Advanced Pain Management S.C. (APMSC) (collectively the “APM Entities”) have agreed to pay $885,452 to settle claims that they violated the False Claims Act by paying kickbacks and by performing medically unnecessary laboratory tests. The APM Entities are headquartered in the Milwaukee, Wisconsin area.[Read More…]
- Department Press Briefing – February 12, 2021By Sam NewsFebruary 13, 2021Ned Price, Department [Read More…]
- Doctor Pleads Guilty to Not Paying Employment TaxesBy Sam NewsFebruary 12, 2021A doctor, formerly of Great Falls, Virginia, pleaded guilty today to willful failure to pay employment taxes, announced Acting Deputy Assistant Attorney General Stuart M. Goldberg of the Justice Department’s Tax Division and Acting U.S. Attorney Raj Parekh for the Eastern District of Virginia.[Read More…]
- Two Louisiana Return Preparers Plead Guilty to Tax Fraud ConspiracyBy Sam NewsFebruary 10, 2021Two Louisiana tax preparers pleaded guilty today to conspiracy to defraud the United States, announced Acting Deputy Assistant Attorney General Stuart M. Goldberg of the Justice Department’s Tax Division and U.S. Attorney Peter G. Strasser for the Eastern District of Louisiana.[Read More…]
- U.S. Special Envoy for Yemen Lenderking’s Travel to Saudi Arabia and OmanBy Sam NewsApril 30, 2021
- Two Bizarre Brown Dwarfs Found With Citizen Scientists’ HelpBy Sam NewsSeptember 26, 2020Data from NASA’s [Read More…]
- U.S. Postal Service: Volume, Performance, and Financial Changes since the Onset of the COVID-19 PandemicBy Sam NewsApril 29, 2021What GAO Found In 2020, the majority of which was affected by the COVID-19 pandemic, the U.S. Postal Service (USPS) experienced a 9 percent drop in total mail volume when compared to 2019. The overall drop was primarily due to a 4 percent dip in First-Class Mail and a 14 percent decline in Marketing Mail (such as advertisements). Despite a drop in total volume, 2020 package volume rose by 32 percent. A surge of election-related mail caused a temporary spike in total mail volume in September and October 2020, before falling again by year end. Overall, USPS's nationwide on-time performance fell in 2020. Average monthly on-time performance for First-Class Mail decreased from 92 percent in 2019 to 87 percent in 2020. However, decreases were more significant in certain USPS districts at different times, and nationally in December 2020. On-time performance was 48 percent in New York in April and 61 percent in Baltimore in September—both of which were nearly 90 percent prior to the pandemic (see figure). Further, national on-time performance dipped to 69 percent in December. In February 2021, the Postmaster General stated that on-time performance was affected by employees' decreased availability in COVID-19 hot spots and a surge in holiday package volume. 2020 Average Monthly On-Time Performance for First-Class Mail in Baltimore, Detroit, and New York Postal Districts USPS's revenue increased in 2020 but not enough to avoid a net loss of $8.1 billion. Rapid growth and price increases for packages, resulted in a net revenue increase of $4.3 billion. However, USPS's expenses grew by $4.4 billion, including COVID-19 related expenses, such as personal protective equipment. USPS took some cost-reduction actions in 2020 and released a new strategic plan in March 2021 that also has cost-reduction actions. In May 2020, GAO concluded that absent congressional action to transform USPS, USPS's financial problems would worsen, putting its mission and financial solvency in greater peril. The further deterioration of USPS's financial position since the start of the pandemic makes the need for congressional action even more urgent. Why GAO Did This Study USPS plays a critical role in the nation's communications and commerce. However, USPS's financial viability is not on a sustainable path and has been on GAO's High Risk List since 2009. The COVID-19 pandemic has highlighted the role of USPS in the nation's economy as well as USPS's financial difficulties. Responding to these concerns, the CARES Act, as amended in late 2020, provided USPS up to $10 billion in additional funding. The CARES Act included a provision for GAO to report on its monitoring and oversight efforts related to the COVID-19 pandemic. This report examines changes in USPS's (1) mail volume, (2) on-time performance, and (3) revenue and expenses from January through December 2020. GAO analyzed USPS mail volume, on-time performance, revenue, and expense data by month for 2020, and compared these data to similar data for 2019. GAO also reviewed its prior work, including its May 2020 report. That report had three matters for congressional consideration on: (1) determining the level of postal services, (2) the extent to which those services should be financially self-sustaining, and (3) the appropriate institutional structure of USPS. GAO also reviewed reports by USPS and the USPS Inspector General. Finally, GAO interviewed USPS officials, two package delivery companies that compete with USPS, and representatives from four mailing associations whose members send the types of mail with the highest volumes in 2020. For more information, contact Jill Naamane at (202) 512-2834 or email@example.com.[Read More…]
- Justice Department Settles Claims Against Toms River, New Jersey Over Zoning Code That Restricts Houses of WorshipBy Sam NewsMarch 10, 2021The Justice Department today announced an agreement with the Township of Toms River, New Jersey, to resolve allegations that the Township violated the Religious Land Use and Institutionalized Persons Act (RLUIPA) by severely restricting where houses of worship can locate within its jurisdiction.[Read More…]
- China-Based Executive at U.S. Telecommunications Company Charged with Disrupting Video Meetings Commemorating Tiananmen Square MassacreBy Sam NewsDecember 18, 2020A complaint and arrest warrant were unsealed today in federal court in Brooklyn charging Xinjiang Jin, also known as “Julien Jin,” with conspiracy to commit interstate harassment and unlawful conspiracy to transfer a means of identification. Jin, an employee of a U.S.-based telecommunications company (Company-1) who was based in the People’s Republic of China (PRC), allegedly participated in a scheme to disrupt a series of meetings in May and June 2020 held to commemorate the June 4, 1989 Tiananmen Square massacre in the PRC. The meetings were conducted using a videoconferencing program provided by Company-1, and were organized and hosted by U.S-based individuals, including individuals residing in the Eastern District of New York. Jin is not in U.S. custody.[Read More…]
- Responding to Modern Cyber Threats with Diplomacy and DeterrenceBy Sam NewsOctober 20, 2020Dr. Christopher Ashley [Read More…]
- Serbia Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel to [Read More…]
- Grand Juries Carry on During PandemicBy Sam NewsIn U.S CourtsOctober 27, 2020As the federal courts have gradually resumed operations with new pandemic-era health and safety rules in place, one aspect of the courts’ mission is on a fast track: the resumption of grand jury proceedings.[Read More…]
- 6 Things to Know About NASA’s Ingenuity Mars HelicopterBy Sam NewsSeptember 26, 2020The first helicopter [Read More…]
- Tonga Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel [Read More…]
- Just the Facts: Trends in Pro Se Civil Litigation from 2000 to 2019By Sam NewsIn U.S CourtsFebruary 11, 2021Most federal pro se cases are civil actions filed by persons serving time in prison. Pro se prisoner petitions spiked in 2016 after a pair of Supreme Court rulings made it possible for certain prisoners to petition to have their sentences vacated or remanded. Non-prisoners who file pro se actions most often raise civil rights claims.[Read More…]
- Briefing with Acting Assistant Secretary for Western Hemisphere Affairs Ambassador Michael G. Kozak On Human Rights Concerns in CubaBy Sam NewsDecember 9, 2020Michael G. Kozak, Acting [Read More…]
- NASA CubeSat Will Shine a Laser Light on the Moon’s Darkest CratersBy Sam NewsSeptember 26, 2020To support the next wave [Read More…]
- Alabama Man Sentenced to Prison for Tax EvasionBy Sam NewsDecember 14, 2020An Alabama man was sentenced to serve 12 months in prison for tax evasion, Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division and U.S. Attorney Prim Escalona for the Northern District of Alabama announced today.[Read More…]